Coughlin Timothy P
Insider CIK 1376043 · LIFE Director · FATE Director · RTRX Director · VIR Director · ADCT Director · NBIX VP and Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TVTX Travere Therapeutics, Inc. | M Exercise deriv | 2026-06-12 | 2026-06-16 | 10,000 | — | $0 | 0 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-06-12 | 2026-06-16 | 10,000 | $50.07 | $500.7K | 56,250 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise | 2026-06-12 | 2026-06-16 | 10,000 | $26.52 | $265.2K | 66,250 | SEC↗ |
| VIR Vir Biotechnology, Inc. | A Award deriv | 2026-06-09 | 2026-06-10 | 16,000 | — | $0 | 16,000 | SEC↗ |
| VIR Vir Biotechnology, Inc. | A Award deriv | 2026-06-09 | 2026-06-10 | 16,000 | — | $0 | 16,000 | SEC↗ |
| VIR Vir Biotechnology, Inc. | A Award | 2026-06-09 | 2026-06-10 | 8,000 | — | $0 | 8,000 | SEC↗ |
| VIR Vir Biotechnology, Inc. | A Award | 2026-06-09 | 2026-06-10 | 8,000 | — | $0 | 16,000 | SEC↗ |
| ADCT ADC Therapeutics SA | F Tax w/h | 2026-06-03 | 2026-06-03 | 12,600 | $3.08 | $38.8K | 72,400 | SEC↗ |
| ADCT ADC Therapeutics SA | A Award | 2026-06-01 | 2026-06-03 | 45,000 | — | $0 | 85,000 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award deriv | 2026-05-19 | 2026-05-21 | 12,000 | — | $0 | 12,000 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award | 2026-05-19 | 2026-05-21 | 4,000 | — | $0 | 56,250 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-05-15 | 2026-05-19 | 3,250 | $43.49 | $141.3K | 52,250 | SEC↗ |
| ATYR aTYR PHARMA INC | A Award deriv | 2026-05-11 | 2026-05-13 | 50,000 | — | $0 | 50,000 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise deriv | 2025-10-31 | 2025-11-04 | 10,000 | — | $0 | 0 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise deriv | 2025-10-31 | 2025-11-04 | 8,000 | — | $0 | 0 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise | 2025-10-31 | 2025-11-04 | 8,000 | $16.33 | $130.6K | 63,500 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2025-10-31 | 2025-11-04 | 18,000 | $35.03 | $630.5K | 55,500 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise | 2025-10-31 | 2025-11-04 | 10,000 | $17.44 | $174.4K | 73,500 | SEC↗ |
| ADCT ADC Therapeutics SA | A Award deriv | 2025-06-03 | 2025-06-05 | 80,000 | — | $0 | 80,000 | SEC↗ |
| ADCT ADC Therapeutics SA | A Award | 2025-06-03 | 2025-06-05 | 40,000 | — | $0 | 40,000 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award deriv | 2025-05-15 | 2025-05-16 | 19,500 | — | $0 | 19,500 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award | 2025-05-15 | 2025-05-16 | 6,500 | — | $0 | 55,500 | SEC↗ |
| ATYR aTYR PHARMA INC | A Award deriv | 2025-05-01 | 2025-05-02 | 50,000 | — | $0 | 50,000 | SEC↗ |
| FATE FATE THERAPEUTICS INC | A Award deriv | 2024-06-07 | 2024-06-11 | 40,000 | — | $0 | 40,000 | SEC↗ |
| LIFE aTYR PHARMA INC | P Buy | 2024-05-30 | 2024-06-03 | 50,000 | $1.75 | $87.5K | 56,000 | SEC↗ |
| LIFE aTYR PHARMA INC | A Award deriv | 2024-05-22 | 2024-05-23 | 24,000 | — | $0 | 24,000 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award deriv | 2024-05-08 | 2024-05-10 | 19,500 | — | $0 | 19,500 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award | 2024-05-08 | 2024-05-10 | 6,500 | — | $0 | 49,000 | SEC↗ |
| FATE FATE THERAPEUTICS INC | A Award deriv | 2023-06-06 | 2023-06-07 | 40,000 | — | $0 | 40,000 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award deriv | 2023-05-17 | 2023-05-19 | 13,500 | — | $0 | 13,500 | SEC↗ |
| LIFE aTYR PHARMA INC | A Award deriv | 2023-05-17 | 2023-05-19 | 12,000 | — | $0 | 12,000 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award | 2023-05-17 | 2023-05-19 | 4,500 | — | $0 | 42,500 | SEC↗ |
| LIFE aTYR PHARMA INC | G Gift | 2023-05-17 | 2023-05-19 | 6,000 | — | $0 | 0 | SEC↗ |
| LIFE aTYR PHARMA INC | G Gift | 2023-05-17 | 2023-05-19 | 6,000 | — | $0 | 6,000 | SEC↗ |
| LIFE aTYR PHARMA INC | M Exercise deriv | 2023-04-26 | 2023-04-28 | 6,000 | — | $0 | 0 | SEC↗ |
| LIFE aTYR PHARMA INC | M Exercise | 2023-04-26 | 2023-04-28 | 6,000 | — | $0 | 6,000 | SEC↗ |
| FATE FATE THERAPEUTICS INC | A Award deriv | 2022-06-09 | 2022-06-13 | 11,893 | — | $0 | 11,893 | SEC↗ |
| FATE FATE THERAPEUTICS INC | A Award | 2022-06-09 | 2022-06-13 | 8,650 | — | $0 | 9,892 | SEC↗ |
| FATE FATE THERAPEUTICS INC | S Sale | 2022-06-03 | 2022-06-06 | 1,439 | $22.81 | $32.8K | 57,632 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award deriv | 2022-05-11 | 2022-05-12 | 9,000 | — | $0 | 9,000 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award | 2022-05-11 | 2022-05-12 | 3,000 | — | $0 | 38,000 | SEC↗ |
| LIFE aTYR PHARMA INC | A Award deriv | 2022-04-26 | 2022-04-28 | 6,000 | — | $0 | 6,000 | SEC↗ |
| FATE FATE THERAPEUTICS INC | A Award deriv | 2021-06-02 | 2021-06-04 | 4,334 | — | $0 | 4,334 | SEC↗ |
| FATE FATE THERAPEUTICS INC | A Award | 2021-06-02 | 2021-06-04 | 2,681 | — | $0 | 59,071 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award deriv | 2021-05-14 | 2021-05-18 | 9,000 | — | $0 | 9,000 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award | 2021-05-14 | 2021-05-18 | 3,000 | — | $0 | 35,000 | SEC↗ |
| LIFE aTYR PHARMA INC | A Award deriv | 2021-04-28 | 2021-04-29 | 1,428 | — | $0 | 1,428 | SEC↗ |
| RTRX Retrophin, Inc. | A Award deriv | 2020-05-15 | 2020-05-19 | 9,000 | — | $0 | 9,000 | SEC↗ |
| RTRX Retrophin, Inc. | A Award | 2020-05-15 | 2020-05-19 | 3,000 | — | $0 | 32,000 | SEC↗ |
| LIFE aTYR PHARMA INC | A Award deriv | 2020-05-06 | 2020-05-08 | 1,428 | — | $0 | 1,428 | SEC↗ |
| FATE FATE THERAPEUTICS INC | A Award deriv | 2020-05-01 | 2020-05-05 | 16,000 | — | $0 | 16,000 | SEC↗ |
| LIFE aTYR PHARMA INC | A Award deriv | 2019-05-08 | 2019-05-10 | 20,000 | — | $0 | 20,000 | SEC↗ |
| RTRX Retrophin, Inc. | A Award deriv | 2019-05-08 | 2019-05-10 | 8,000 | — | $0 | 8,000 | SEC↗ |
| RTRX Retrophin, Inc. | A Award | 2019-05-08 | 2019-05-10 | 2,000 | — | $0 | 29,000 | SEC↗ |
| FATE FATE THERAPEUTICS INC | A Award deriv | 2019-05-03 | 2019-05-07 | 16,000 | — | $0 | 16,000 | SEC↗ |
| LIFE aTYR PHARMA INC | A Award deriv | 2018-05-15 | 2018-05-17 | 20,000 | — | $0 | 20,000 | SEC↗ |
| RTRX Retrophin, Inc. | A Award deriv | 2018-05-09 | 2018-05-11 | 10,000 | — | $0 | 10,000 | SEC↗ |
| RTRX Retrophin, Inc. | A Award | 2018-05-09 | 2018-05-11 | 2,500 | — | $0 | 27,000 | SEC↗ |
| FATE FATE THERAPEUTICS INC | A Award deriv | 2018-05-02 | 2018-05-04 | 16,000 | — | $0 | 16,000 | SEC↗ |
| RTRX Retrophin, Inc. | A Award deriv | 2017-05-17 | 2017-05-18 | 10,000 | — | $0 | 10,000 | SEC↗ |
| RTRX Retrophin, Inc. | A Award | 2017-05-17 | 2017-05-18 | 2,500 | — | $0 | 24,500 | SEC↗ |
| LIFE aTYR PHARMA INC | A Award deriv | 2017-05-09 | 2017-05-11 | 20,000 | — | $0 | 20,000 | SEC↗ |
| FATE FATE THERAPEUTICS INC | A Award deriv | 2017-05-02 | 2017-05-04 | 25,000 | — | $0 | 25,000 | SEC↗ |
| LIFE aTYR PHARMA INC | A Award deriv | 2017-04-07 | 2017-04-10 | 32,000 | — | $0 | 32,000 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2017-02-06 | 2017-02-08 | 963 | $43.14 | $41.5K | 137,961 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2017-02-03 | 2017-02-06 | 1,500 | $42.55 | $63.8K | 136,324 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2017-01-17 | 2017-01-18 | 1,750 | $40.65 | $71.1K | 134,824 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2017-01-10 | 2017-01-12 | 1,750 | $43.37 | $75.9K | 133,124 | SEC↗ |
| FATE FATE THERAPEUTICS INC | P Buy | 2016-11-23 | 2016-11-28 | 56,390 | $2.66 | $150.0K | 56,390 | SEC↗ |
| RTRX Retrophin, Inc. | A Award deriv | 2016-05-18 | 2016-05-19 | 8,000 | — | $0 | 8,000 | SEC↗ |
| RTRX Retrophin, Inc. | A Award | 2016-05-18 | 2016-05-19 | 2,000 | — | $0 | 22,000 | SEC↗ |
| FATE FATE THERAPEUTICS INC | A Award deriv | 2016-05-11 | 2016-05-13 | 25,000 | — | $0 | 25,000 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2016-02-05 | 2016-02-09 | 20,500 | — | $0 | 20,500 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2016-02-05 | 2016-02-09 | 10,200 | — | $0 | 10,200 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2016-02-05 | 2016-02-09 | 48,500 | — | $0 | 48,500 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2016-02-03 | 2016-02-04 | 1,500 | $38.06 | $57.1K | 131,374 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2016-01-19 | 2016-01-21 | 1,750 | $46.69 | $81.7K | 129,874 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2016-01-11 | 2016-01-13 | 1,750 | $44.25 | $77.4K | 128,124 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2015-10-16 | 2015-10-19 | 25,000 | $47.78 | $1.19M | 126,374 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2015-07-20 | 2015-07-21 | 20,000 | $5.76 | $115.2K | 85,000 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2015-07-20 | 2015-07-21 | 20,000 | $55.00 | $1.10M | 101,374 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2015-07-20 | 2015-07-21 | 20,000 | $5.76 | $115.2K | 121,374 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2015-07-13 | 2015-07-14 | 20,000 | $5.76 | $115.2K | 105,000 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2015-07-13 | 2015-07-14 | 20,000 | $50.00 | $1.00M | 101,374 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2015-07-13 | 2015-07-14 | 20,000 | $5.76 | $115.2K | 121,374 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2015-06-08 | 2015-06-10 | 41,062 | $2.59 | $106.4K | 0 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2015-06-08 | 2015-06-10 | 18,938 | $2.59 | $49.0K | 0 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2015-06-08 | 2015-06-10 | 18,938 | $2.59 | $49.0K | 120,312 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2015-06-08 | 2015-06-10 | 60,000 | $45.08 | $2.70M | 101,374 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2015-06-08 | 2015-06-10 | 41,062 | $2.59 | $106.4K | 161,374 | SEC↗ |
| FATE FATE THERAPEUTICS INC | A Award deriv | 2015-05-13 | 2015-05-15 | 10,000 | — | $0 | 10,000 | SEC↗ |
| RTRX Retrophin, Inc. | A Award deriv | 2015-03-31 | 2015-04-02 | 40,000 | — | $0 | 40,000 | SEC↗ |
| RTRX Retrophin, Inc. | A Award | 2015-03-31 | 2015-04-02 | 20,000 | — | $0 | 20,000 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2015-03-20 | 2015-03-24 | 40,000 | $2.59 | $103.6K | 60,000 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2015-03-20 | 2015-03-24 | 40,000 | $2.59 | $103.6K | 141,374 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2015-03-20 | 2015-03-24 | 40,000 | $44.49 | $1.78M | 101,374 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2015-02-03 | 2015-02-05 | 80,000 | $32.99 | $2.64M | 80,000 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2015-02-03 | 2015-02-05 | 12,000 | — | $0 | 12,000 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2015-01-16 | 2015-01-21 | 1,750 | $30.81 | $53.9K | 101,374 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2015-01-12 | 2015-01-13 | 1,750 | $28.37 | $49.6K | 99,624 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2015-01-08 | 2015-01-09 | 10,000 | $2.59 | $25.9K | 100,000 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2015-01-08 | 2015-01-09 | 10,000 | $27.25 | $272.5K | 97,874 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2015-01-08 | 2015-01-09 | 10,000 | $2.59 | $25.9K | 107,874 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2014-12-19 | 2014-12-19 | 10,000 | $2.59 | $25.9K | 110,000 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2014-12-19 | 2014-12-19 | 10,000 | $2.59 | $25.9K | 107,874 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2014-12-19 | 2014-12-19 | 10,000 | $24.02 | $240.2K | 97,874 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2014-12-18 | 2014-12-19 | 20,000 | $2.59 | $51.8K | 120,000 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2014-12-18 | 2014-12-19 | 10,000 | $23.25 | $232.5K | 107,874 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2014-12-18 | 2014-12-19 | 20,000 | $2.59 | $51.8K | 117,874 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2014-12-18 | 2014-12-19 | 10,000 | $23.11 | $231.1K | 97,874 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2014-12-10 | 2014-12-12 | 10,000 | $2.59 | $25.9K | 140,000 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2014-12-10 | 2014-12-12 | 10,000 | $5.12 | $51.2K | 140,000 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2014-12-10 | 2014-12-12 | 10,000 | $2.59 | $25.9K | 107,874 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2014-12-10 | 2014-12-12 | 10,000 | $5.12 | $51.2K | 107,874 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2014-12-10 | 2014-12-12 | 10,000 | $21.95 | $219.5K | 97,874 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2014-12-10 | 2014-12-12 | 10,000 | $21.00 | $210.0K | 97,874 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2014-11-28 | 2014-12-02 | 10,000 | $5.12 | $51.2K | 10,000 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2014-11-28 | 2014-12-02 | 10,000 | $20.14 | $201.4K | 97,874 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | X Exercise deriv | 2014-10-31 | 2014-11-03 | 10,000 | $2.59 | $25.9K | 150,000 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2014-10-31 | 2014-11-03 | 10,000 | $19.00 | $190.0K | 97,874 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | X Exercise deriv | 2014-10-30 | 2014-10-30 | 10,000 | $2.59 | $25.9K | 160,000 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2014-10-30 | 2014-10-30 | 10,000 | $18.62 | $186.2K | 97,874 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | X Exercise deriv | 2014-10-28 | 2014-10-30 | 10,000 | $5.12 | $51.2K | 20,000 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2014-10-28 | 2014-10-30 | 10,000 | $18.00 | $180.0K | 97,874 | SEC↗ |
| FATE FATE THERAPEUTICS INC | A Award deriv | 2014-06-06 | 2014-06-09 | 10,000 | — | $0 | 10,000 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2014-01-16 | 2014-01-21 | 86,000 | $19.59 | $1.68M | 86,000 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2014-01-16 | 2014-01-21 | 14,000 | — | $0 | 14,000 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2014-01-16 | 2014-01-21 | 75,000 | — | $0 | 75,000 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2014-01-10 | 2014-01-13 | 1,750 | $18.56 | $32.5K | 97,874 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | X Exercise deriv | 2014-01-07 | 2014-01-08 | 53,450 | $11.44 | $611.5K | 0 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | X Exercise deriv | 2014-01-07 | 2014-01-08 | 16,550 | $11.44 | $189.3K | 53,450 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2014-01-07 | 2014-01-08 | 70,000 | $16.75 | $1.17M | 96,124 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | X Exercise deriv | 2013-08-21 | 2013-08-22 | 19,035 | $11.44 | $217.8K | 70,000 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2013-08-21 | 2013-08-22 | 19,035 | $15.05 | $286.5K | 96,124 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | X Exercise deriv | 2013-08-05 | 2013-08-07 | 10,965 | $11.44 | $125.4K | 89,035 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2013-08-05 | 2013-08-07 | 10,965 | $14.99 | $164.4K | 96,124 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2013-01-10 | 2013-01-14 | 86,000 | $8.65 | $743.9K | 86,000 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2013-01-10 | 2013-01-14 | 14,000 | — | $0 | 14,000 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2012-01-12 | 2012-01-17 | 120,000 | $8.66 | $1.04M | 120,000 | SEC↗ |